Articles in section Licensing
| << Joint Venture | 480 articles | Mergers & Acquisitions >> |
| Pages 1 2 3 4 5 .. 48 | Next >> |
-
GSK Pays US$66 M Upfront for Spero’s Late-Stage Antibiotic
-
Zealand Pharma Signs Licensing Agreement with Novo Nordisk for Zegalogue®
-
GSK Signs US$1.4 B ADC Option Deal with Mersana
-
Ipsen Enters Immuno-Oncology Partnership with Marengo Therapeutics for US$1.6 B
-
Avista Therapeutics Signs Gene Therapy Partnership with Roche for US$1 B
-
Vertex Signs Gene Editing Partnership with Verve for US$466 M
-
Takeda Licenses F-star’s Immuno-oncology Bispecific Antibody Technology
-
Immatics and Bristol Myers Squibb Expand Alliance to Develop Cell Therapy Programmes
-
MorphoSys Out-licenses Two Oncology Antibodies to HIBio
-
Biogen Licenses Parkinson’s Drug from Alectos Therapeutics for up to US$722.5 M
RSS